USA Financial Formulas’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-5,921
Closed -$348K 330
2018
Q3
$348K Buy
+5,921
New +$348K 0.09% 195